Animal Model Market 2024 - By Share, Size, Trend, Demand, Analysis By Top Leading Players And Forecast Till 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Animal Model Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $2.69 billion In 2028 At A CAGR Of 8.9% :

The animal model market size has grown strongly in recent years. It will grow from $1.76 billion in 2023 to $1.92 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to the rising adoption of animal models for biomedical research, surging expenditure and high investments in drug development and discovery, growing focus on precision medicine, and extensive applications of animal models in the healthcare industry.

The animal model market size is expected to see strong growth in the next few years. It will grow to $2.69 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to advancements in genetic engineering, increased focus on personalized medicine, rising prevalence of chronic diseases, growing need for effective vaccines and therapeutics, increased investment in biomedical research. Major trends in the forecast period include increasing demand for animal models in drug discovery and development, rising prevalence of chronic diseases, physiological similarities between humans and animals reduces drug development time, growing consumption of personalized medicine driving the demand for humanized mice models, high growth of the market due to rising adoption of animal models for biomedical research.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=15510&type=smp

Animal Model Market Major Segments
The animal model market covered in this report is segmented -

1) By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Other Animal Types
2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies
3) By Application: Drug Discovery And Development, Basic Research, Other Applications
4) By End User: Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations

Key Driver - Rising Demand For Paper Drying Systems Catalyzes Growth In The Food And Beverage Industry

The growing pharmaceutical research and development investment activities are expected to propel the growth of the animal model market going forward. Pharmaceutical research and development is a complex process where science and innovation converge to create medical advancements. With the rise of innovative therapies, pursuing treatments for complex diseases, alongwith driving scientific curiosity and commercial opportunities in the healthcare sector moves research and development process. Animal models are crucial in pharmaceutical research and development for predicting drug efficacy, safety, and toxicity, providing insights into biological mechanisms, and aiding in developing new treatments by mimicking human physiological responses and disease progression in controlled settings. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations, a Belgium-based trade association and lobbying organization, spending on pharmaceutical research and development across Europe was €44,500 ($47999) in 2022 and €42,533 million ($45877 million) in 2021, an increase of 7.82% from €39,442 ($42543 million) in 2020. Therefore, the growing pharmaceutical research and development investment is driving the animal model market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=15510&type=smp

Prominent Trend - Triple-Immunodeficient Mice And Their Impact On Biomedical Research

Major companies operating in the animal model market are focusing on developing innovative products, such as triple-immunodeficient animal models, to enhance the accuracy and reliability of preclinical studies, support advanced biomedical research, and facilitate the development of novel therapies for complex human diseases. Triple-immunodeficient animal models are specially engineered animals, typically mice, that lack three key immune system components. These models are invaluable in biomedical research, particularly for studying human diseases and developing new treatments. For instance, in January 2024, Charles River Laboratories International, Inc., a US-based pharmaceutical company, launched NCG mouse strains, a triple-immunodeficient mouse model for oncology research. NCG mice are triple immunodeficient, lacking functional/mature T, B, and NK cells, and exhibit reduced macrophage and dendritic cell function. These animal models can host xenograft cells, tissues, and human immune system components. This mouse model is ideal for research in oncology, immunology, tumor biology, infectious diseases, graft-versus-host disease (GvHD), diabetes, regenerative medicine, hematopoiesis, and tissue transplant studies. NCG mice can also create humanized mice by engrafting PBMCs or CD34+ stem cells, closely mimicking the human immune system.

Animal Model Market Players
Major companies operating in the animal model market are Eurofins Scientific SE, Charles River Laboratories International Inc., Pharmaron Beijing Co Ltd, Inotiv Inc., Biocytogen, Taconic Biosciences Incorporation, Cyagen Biosciences, Trans Genic Incorporation, Crown Bioscience Incorporation, Harbor BioMed, PharmaLegacy, PsychoGenics, Biomere Biomedical Research Models Inc., Genoway S.A, Alloy Therapeutics, Janvier Labs, Hera Biolabs, Ozgene Pty Ltd, Transposagen Biopharmaceuticals Inc., KMT Hepatech Inc., AniLocus Inc., BioXpert, Harlan Sprague Dawley Inc.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the animal model market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Animal Model Market Report Structure
3. Animal Model Market Trends And Strategies
4. Animal Model Market - Macro Economic Scenario
5. Animal Model Market Size And Growth
…..
27. Animal Model Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.